Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Drawbacks of Consumer Genetic Testing – And What Pharma Can Do To Make It Better

Posted on October 16th, 2018 by

Pharma R&D

dna

Genetic testing has become a big hit with consumers. Companies like Ancestry.com and 23andMe flood the airwaves with commercials about the joy of using DNA testing to find out about your heritage. But another reason genetic testing is attracting consumers is because it also can tell people about some of their genetic health risks. Continue reading “Drawbacks of Consumer Genetic Testing – And What Pharma Can Do To Make It Better” »

The Delicate Balance of Drug Risks vs. Benefits

Posted on October 16th, 2018 by

Pharma R&D

Pills

For many people, taking medication is a regular part of their daily routine, and these medicines are relied upon to treat disease and improve health.  The benefits of medicines are the helpful effects you get when you use them, such as the lowering blood pressure, curing infection, or relieving pain. Continue reading “The Delicate Balance of Drug Risks vs. Benefits” »

Rapid Growth and Promising Partnerships

Posted on October 11th, 2018 by

The Hive

beacon new

Beacon Discovery is a science-focused company with a huge breadth of experience in discovering and developing drugs that target G-Protein Coupled Receptors (GPCRs) – and, in the two years since our founding in September 2016, we have already achieved some important milestones. Continue reading “Rapid Growth and Promising Partnerships” »

Doing our part to improve drug safety

Posted on October 2nd, 2018 by

Pharma R&D

Pharmacovigilance

Pharmacovigilance and drug safety teams are never short of work. There’s a vast amount of peer-reviewed literature to sift through for adverse event information. Over 800,000 pharmacology and biomedicine articles Continue reading “Doing our part to improve drug safety” »

Rare Disease Drug Repurposing Datathon Launching

Posted on September 28th, 2018 by

Pharma R&D

Datathon

Would you and your organization like to use your skills and expertise to help defeat rare diseases? On October 9, the Rare Disease Drug Repurposing Datathon is launching, offering data scientists a special opportunity Continue reading “Rare Disease Drug Repurposing Datathon Launching” »

Finding Support and Success Along the Development Path

Posted on September 28th, 2018 by

The Hive

The Hive
We founded 4P-Pharma at the end of 2014 in response to the urgent need to increase the number of innovative therapeutics entering the developing drug pipeline for cancer and inflammatory diseases. Our idea was to detect the most promising technologies Continue reading “Finding Support and Success Along the Development Path” »

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 59


About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.